DuoGenic StemCells Corporation(TW:7607)
NT$13.20+0.90 (+7.32%)
TW:7607
DuoGenic StemCells Corporation Revenue
NT$13.20
At close:+0.90 (+7.32%)
DuoGenic StemCells Corporation (7607) Revenue
DuoGenic StemCells Corporation Revenue
DuoGenic StemCells Corporation had a revenue of 10.31M in the quarter ending Jun 30, 2026, with 0.20%. This bring the company's revenue in the last twelve months to 20.60M, Decreased 0.45%. In the fiscal year ending Dec 31, 2025, DuoGenic StemCells Corporation had annual revenue of 20.69M with 71.70% growth.
- Revenue (ttm)
- 20.60M
- Revenue Growth
- 18.63%
- P/S Ratio
- 21.79
- Revenue/Employee
- TWD 1,379,533
- Employees
- 15
- Market Cap
- TWD 450.83M
Revenue Chart
DuoGenic StemCells Corporation Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 20.69M | 8.64M | 71.70% |
| Dec 31, 2024 | 12.05M | -1.61M | -11.82% |
| Dec 31, 2023 | 13.67M | 6.80M | 99.17% |
| Dec 31, 2022 | 6.86M | 4.57M | 198.74% |
| Dec 31, 2021 | 2.30M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.